Kala Bio said it laid off most of its employees after receiving notice that its lender, Oxford Finance, intends to foreclose on all of its remaining assets. The move follows the biotech company's ...
Shares of KALA BIO KALA have nosedived 88.3% in a month after the company announced the failure of a mid-stage study evaluating its only clinical pipeline candidate, KPI-012, for the treatment of ...
The Ziro Music Festival 2025 in Arunachal Pradesh featured four days of folk, indie, and global music, focusing on sustainability and community. Held in Ziro Valley, it included bamboo stages, plastic ...
Kala Bio, Inc. (NASDAQ:KALA), a biotech company with a market capitalization of $10.74 million and showing significant stock volatility, announced it received a written notice of default from Oxford ...
The Chhattisgarh government has declared the recently released Chhattisgarhi film ‘Balidani Raja Guru Balakdas’, based on the life of Satnami sect leader Raja Guru Balakdas, tax-free in the state. The ...
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Kala Pharmaceuticals ( (KALA)) has shared ...
Kala Bio will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the drug developer's shares down 93% in ...
Fintel reports that on September 8, 2025, Mizuho initiated coverage of KALA BIO (NasdaqCM:KALA) with a Outperform recommendation. Analyst Price Forecast Suggests 29.69% Upside As of September 3, 2025, ...
(RTTNews) - Biopharmaceutical company KALA BIO, Inc. (KALA) announced Tuesday that Todd Bazemore has been named President and Chief Executive Officer (CEO) and appointed to the Board of Directors.
Kabuli chana and kala chana are both popular legumes in Indian cuisine and around the world. While they belong to the same species (Cicer arietinu) they differ in appearance and taste. Kabuli chana is ...
On Monday, Oppenheimer analysts assumed coverage of Kala Bio (NASDAQ: KALA) stock with an Outperform rating and a price target of $15.00, representing a significant premium to the current price of ...
Kala’s music is more than just a thread of his creativity – it’s the whole tapestry. Ali’ikai Kala holds certificates in music business and music production through UCLA Extension. However, he is also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results